Generic Name：
Ipratropium Bromide Inhalation Solution
Indications：
Ipratropium bromide inhalation Solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
Dosage Forms and Strengths
Inhalation Solution: 0.5 mg/2 mL
Generic Name：Ipratropium Bromide Inhalation Solution
Indications：Ipratropium bromide inhalation Solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
Dosage Forms and Strengths：Inhalation Solution: 0.5 mg/2 mL
Dosage and Administration：
Maintenance: The usual dosage of ipratropium bromide inhalation solution is 500 mcg (1 Unit-Dose Vial) administered three to four times a day by oral nebulization, with doses 6 to 8 hours apart.
Acute Exacerbation: One single-dose vial per administration; repeat dosing can be done until patient condition stabilizes. Dosing interval to be determined by the physician.
Quick Navigation
Service Hotline
Quick
Navigation
Service
Hotline
Official WeChat Official Account
Copyright © Joincare Pharmaceutical Group Industry Co., Ltd. All Rights Reserved. Powered by：www.300.cn Zhuhai 粤ICP备14024104号
